You are here: Industry Insights > cancer

News List

Vitamin A Linked to Lower Odds of Common Skin Cancer drugs
August 01, 2019
Wondering if you can do more than slap on some sunscreen to prevent?skin cancer? A new study suggests that getting more vitamin A may help.
FDA Approves Nubeqa (darolutamide) for Men with Non-Metastatic Castration-Resistant Prostate Cancer drugs
August 01, 2019
The U.S. Food and Drug Administration (FDA) today approved Nubeqa??(darolutamide), an androgen receptor inhibitor (ARi)...
Global Burden of Childhood Cancers Examined drugs
July 31, 2019
Childhood cancers have a considerable disability-adjusted life-year (DALY) burden, which disproportionately affects countries with low resources...
Childhood Cancer Steals Over 11 Million Years of Healthy Life: Study drugs
July 31, 2019
Researchers are closing in on the toll of childhood?cancer, finding it stole 11.5 million years of healthy life lost worldwide in 2017.
TYME Technologies, NYU Langone to Advance Metastatic Cancer Treatment contractpharma
July 31, 2019
Aims to examine TYME’s metabolism-based cancer treatment, SM-88.
Delay in Time to Chemo Impacts Survival in Breast Cancer drugs
July 30, 2019
Delay in initiation of chemotherapy is associated with poorer overall survival for breast cancer...
Female Oncologists Attend Fewer Conferences Than Men drugs
July 26, 2019
Female oncologists attend significantly fewer conferences than male oncologists, according to a research letter published online in?JAMA Oncology.
Cancer Risks Examined in Rheumatoid Arthritis Patients drugs
July 25, 2019
Compared with the general population, there is an increased risk for certain cancers in patients with rheumatoid arthritis (RA) in Singapore...
Breast Implants Tied to Rare Cancer Risk Recalled drugs
July 25, 2019
Allergan's textured breast implants will be recalled due to their link to a rare cancer, the U.S. Food and Drug Administration announced Wednesday.
Some of Most Common, Deadly Cancers Get the Least Research Money drugs
July 25, 2019
Many of the most common or deadliest cancers receive the least research funding from nonprofits, a new study finds.